Español »
Embedded Files
Non-Opiod│Non-Narcotic Prescription Policy
Our practice prioritizes patient safety through evidence-based pain management. Please note that this office does not maintain an inventory of addictive narcotics│opioids on the premises. Our practice utilizes the Prescription Monitoring Program (PMP) during patient intake and clinical evaluations.
Our post-operative protocols typically emphasize utilizing non-addictive, non-opioid │ non-narcotic medications. Typically, non-addictive, non-controlled prescriptions are transmitted electronically to the patient's pharmacy of record following a clinical evaluation. We do not provide long-term pain management or refills for addictive narcotics│opioids.
If you are experiencing a medical emergency or require specialized opioid│narcotic pain management beyond the surgical scope of this practice, please call 911 or visit the nearest emergency room.
Definitions
Definitions
What is the PMP? The Prescription Monitoring Program (PMP) is a secure, state-regulated database that tracks the prescription history of controlled substances. It allows licensed healthcare providers to view a patient's recent history for heavily regulated medications—such as opioids and narcotics.
How our practice uses the PMP: We review the PMP as a standard safety protocol to verify patient records, prevent dangerous drug interactions, and ensure strict compliance with our non-narcotic post-operative guidelines. This database review is a mandatory step in our clinical evaluation process before any surgical treatment is initiated.
1. Opioid (The Medical Term)
1. Opioid (The Medical Term)
An opioid is a specific class of drugs that interact with opioid receptors in the brain and body to reduce pain. This term covers everything from natural substances derived from the opium poppy to fully synthetic, lab-made chemicals.
How it works: It chemically blocks pain signals.
Examples: Morphine, Codeine, Hydrocodone (Vicodin), Oxycodone (Percocet), Fentanyl, and Heroin.
Clinical Significance: "Opioid" is a precise pharmacological definition based on how the drug behaves biologically in the human body.
2. Narcotic (The Legal Term)
2. Narcotic (The Legal Term)
Historically, narcotic came from the Greek word for "numbness" or "stupor" and originally referred to any drug that induced sleep or dulled pain. Today, "narcotic" is primarily a legal and law enforcement designation.
How it is defined: Under U.S. federal law (the Controlled Substances Act), a narcotic is legally defined as opium, opiates, derivatives of opium, or cocaine (which is chemically a stimulant, not an opioid, but is legally classified as a narcotic due to its high abuse potential and regulatory restrictions).
Legal Significance: In a statutory context, "narcotic" is used to define heavily regulated, addictive, or illicit controlled substances.
Evidence Based Literature for Non Opiod Therapy:
1. The Comprehensive Cochrane Systematic Reviews
1. The Comprehensive Cochrane Systematic Reviews
The Cochrane Collaboration provides the gold-standard data used to evaluate acute pain regimens. The Number Needed to Treat (NNT) metric indicates how many patients must take a drug for one person to achieve at least 50% pain relief over 4 to 6 hours. An NNT closer to 1.0 indicates a highly effective drug.
Derry et al. (2013) & Moore et al. (2015): In an exhaustive overview of Cochrane systematic reviews evaluating single-dose oral analgesics for acute postoperative pain, the combination of ibuprofen 200 mg and acetaminophen 500mg achieved an exceptional NNT of 1.6 (Derry et al., 2013).
How it Compares to Opioids: For context, standard opioid/acetaminophen combinations (like codeine or low-dose oxycodone formulations) typically score significantly higher NNTs, often ranging from 2.2 to well over 4.0, while carrying a far greater side-effect profile (Derry et al., 2013; Moore et al., 2015). The systematic reviews conclusively demonstrated that the dual-action non-opioid profile provides longer-lasting pain control and drops the necessity for "rescue medication" down significantly compared to monotherapies (Derry et al., 2013).
2. The Impacted Third-Molar Clinical Model
2. The Impacted Third-Molar Clinical Model
In pain management research, the surgical extraction of impacted third molars (wisdom teeth) is widely utilized as the industry-standard clinical model for evaluating acute bone and soft-tissue pain.
The Landmark 1,800-Patient Study: A massive landmark trial involving more than 1,800 post-surgical dental patients directly pitted the non-opioid combination 400 mg ibuprofen, 500mg acetaminophen against a standard narcotic regimen (hydrocodone/acetaminophen). The study demonstrated that the non-opioid combination provided superior pain control, higher overall patient satisfaction, and significantly less interference with activities of daily living during the critical first 48 hours post-op.
The Gender-Based Follow-Up (Rutgers Health, published in JAMA Network Open): A follow-up analysis published in JAMA Network Open specifically evaluated these findings across genders. It confirmed that despite women historically reporting higher baseline postoperative pain sensitivities, the 2:1 synergistic non-opioid therapy provided equal or superior pain relief to opioids across both cohorts, explicitly challenging the clinical assumption that narcotics are necessary for complex surgical extractions.
Phase III Trial Data: Other prospective, randomized, double-blind trials—such as the multi-center Phase III study evaluating fixed-dose combinations—confirmed that combining the two agents results in a significantly greater time-adjusted sum of pain intensity differences (SPID) over a 48-hour period than matching doses of ibuprofen or acetaminophen administered by themselves, without increasing adverse events like nausea or dizziness (PubMed, NCT01420653).
3. Shift in Official Clinical Practice Guidelines
3. Shift in Official Clinical Practice Guidelines
Because the academic literature has become so definitive, major health organizations have formally restructured their clinical guidelines to mandate non-opioid regimens as the primary defense.
The American Dental Association (ADA) Guidelines: The ADA completely altered its clinical protocols, formally designating the combination of acetaminophen and NSAIDs (like ibuprofen) as first-line therapy for managing acute dental pain.
Age-Group Mandates: Following the publication of pediatric pain guidelines, the ADA updated its directives for adolescents and adults, solidifying multimodal non-opioid approaches as the standard of care to intentionally spare patients from early opioid exposure. It was this deep pool of clinical data that eventually led to the fixed-dose combination receiving the first-in-category ADA Seal of Acceptance for acute dental pain management.
References
References
Derry, C. J., Derry, S., & Moore, R. A. (2013). Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain. Cochrane Database of Systematic Reviews, (6). https://doi.org/10.1002/14651858.CD010210.pub2
Moore, R. A., Derry, S., Aldington, D., & Wiffen, P. J. (2015). Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews, (9). https://doi.org/10.1002/14651858.CD008659.pub3
Moore, P. A., & Hersh, E. V. (2013). Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: Translating clinical research to dental practice. The Journal of the American Dental Association, 144(8), 898–908. https://doi.org/10.14219/jada.archive.2013.0201
Page updated
Google Sites
Report abuse